Reducing inflammation supports metabolic stability and contributes to improved long term health
Recent trials have shown: Up to 20% body weight reduction with weekly GLP-1 agonists (Wilding et al., NEJM) Improvements in HbA1c, fasting glucose, and cardiovascular outcomes (Marso et al., NEJM) This drug class is now widely used for: Obesity (with or without diabetes) Type 2 diabetes PCOS-related insulin resistance Metabolic syndrome Common Side Effects and Patient Concerns Despite their benefits, GLP-1 agonists are not without risks or drawbacks
Sanyal, A
Meanwhile, other GLP-1 agonists, such as Ozempic, are actually meant for the treatment of type 2 diabetes
Most people describe the nausea as manageable, similar to mild motion sickness
Available 24/7 for questions, guidance, and tips in the WW app